INLB (Item 9 Labs) Total Liabilities: $59.37 Mil (As of Jun. 2023)


INLB Item 9 Labs Corp INLB
12 GF Score
Price $0.00
View Full Analysis

What is Item 9 Labs Total Liabilities?

Item 9 Labs INLB -99.00% 12 Total Liabilities is $59.37 Mil as of Jun. 2023. GuruFocus rates INLB with a GF Score™ of 12/100.

Item 9 Labs's Total Liabilities for the quarter that ended in Jun. 2023 was $59.37 Mil.

Item 9 Labs's quarterly Total Liabilities increased from Dec. 2022 ($54.31 Mil) to Mar. 2023 ($56.44 Mil) and increased from Mar. 2023 ($56.44 Mil) to Jun. 2023 ($59.37 Mil).

Item 9 Labs's annual Total Liabilities increased from Sep. 2020 ($12.65 Mil) to Sep. 2021 ($30.71 Mil) and increased from Sep. 2021 ($30.71 Mil) to Sep. 2022 ($48.82 Mil).

Item 9 Labs Total Liabilities Historical Data

* Premium members only.

The historical data trend for Item 9 Labs's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Item 9 Labs Total Liabilities Chart

Item 9 Labs Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.90 7.14 12.65 30.71 48.82

Item 9 Labs Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.02 48.82 54.31 56.44 59.37
INLB
12GF Score
Item 9 Labs Corp INLB
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Item 9 Labs Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Item 9 Labs's Total Liabilities for the fiscal year that ended in Sep. 2022 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=40.586+(7.899+-6.1062266354384E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0.336+0+0)
=48.82

Total Liabilities=Total Assets (A: Sep. 2022 )-Total Equity (A: Sep. 2022 )
=110.762-61.941
=48.82

Item 9 Labs's Total Liabilities for the quarter that ended in Jun. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=58.813+(0.145+-1.6653345369377E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0.413+0+0)
=59.37

Total Liabilities=Total Assets (Q: Jun. 2023 )-Total Equity (Q: Jun. 2023 )
=112.015-52.644
=59.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $59.37 Mil mean?
Item 9 Labs (INLB) has a Total Liabilities of $59.37 Mil as of Jun. 2023. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Item 9 Labs and its competitors.
Is Item 9 Labs' Total Liabilities too high?
Item 9 Labs' current Total Liabilities is $59.37 Mil. Overall, Item 9 Labs has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Item 9 Labs' Total Liabilities compare to NEPT and CENBF?
Item 9 Labs' Total Liabilities of $59.37 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Item 9 Labs and its competitors. Item 9 Labs's current Total Liabilities is $59.37 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Item 9 Labs stock overvalued right now?
Item 9 Labs (INLB) has a current Total Liabilities of $59.37 Mil. The current Total Liabilities is $59.37 Mil. Item 9 Labs' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Item 9 Labs (INLB), the current Total Liabilities is $59.37 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Item 9 Labs Business Description

Address 2111 E. Highland Avenue, Suite B375, Phoenix, AZ, USA, 85016
Item 9 Labs Corp is a vertically integrated cannabis operator and dispensary franchisor delivering premium products from its large-scale cultivation and production facilities in the United States. The Item 9 Labs brand specializes in products and user experience across several cannabis categories. The company also offers a dispensary franchise model through the national Unity Rd. retail brand. Easing barriers to entry, the franchise provides an opportunity for both new and existing dispensary owners to leverage the knowledge, resources, and ongoing support needed to thrive in their state compliantly and successfully. It also brings industry practices to markets nationwide through distinctive retail experience, cultivation capabilities, and product innovation.
12GF Score

Get the complete analysis for INLB

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price